Living Cell Technologies Share Price and Company Fundamentals



Price
$0.006
Change
0.001 (20.000%)
52 week
0.005 - 0.025

Last traded: Last Friday at 3:50 AM

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

4.28

Dividend yield

Beta

0.67

Market cap

-

Enterprise value

-

Company profile

Primary activitiesLiving Cell Technologies - cell therapy for neurodegenerative diseases.
Industry / SectorBiotechnology / Healthcare
Websitehttps://www.lctglobal.com
Mailing address330 Collins Street Level 7 Melbourne VIC 3000 Australia
Phone / Fax61 3 8689 9997 / 61 3 9602 4709
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Living Cell Technologies does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Living Cell Technologies.

NameTitleAgeTotal Pay
Dr. Bernard Tuch BSc, FRACP, GAICD, MBBS (Hons), Ph.D.Exec. Chairman & Interim CEO7068.54k
Mr. Daya UkaChief Financial Officer153.71k
Dr. Belinda Di BartoloChief Operating Officer
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSPCompany Sec.57

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-500.05%

Return on assets

-33.30%

Return on equity

-68.64%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Living Cell Technologies is and its enterprise value is .

The LCT's stocks Beta value is 0.67 making it 33% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Living Cell Technologies (LCT)

Living Cell Technologies (ASX:LCT) Frequently Asked Questions

1. What is Living Cell Technologies's Stock Symbol?

Living Cell Technologies trades on ASX under the ticker symbol "LCT".

2. What is Living Cell Technologies's stock price today?

One share of LCT stock can currently be purchased for approximately $0.006.

3. How can I contact Living Cell Technologies?

Living Cell Technologies's mailing address is 330 Collins Street Level 7 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 8689 9997.

4. What is Living Cell Technologies's official website?

The official website of Living Cell Technologies is https://www.lctglobal.com.

5. Which share registry manages Living Cell Technologies's stock?

Living Cell Technologies's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.